Back to FATE

Redmile Group, LLC → FATE

Redmile Group, LLC FATE Position History

Fate Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$30.5M
Q3 2026
Peak value
$34.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$12.6M
Q1 2026$15.4M
Q2 2026$34.8M
Q3 2026$30.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$30.5M12.87M——
Q2 2026$34.8M12.87M——
Q1 2026$15.4M12.87M——
Q4 2025$12.6M12.87M——

Other funds holding FATE

Other Redmile Group, LLC positions

SRRK

SCHOLAR ROCK HLDG CORP

$445.7M
SRRK

SCHOLAR ROCK HLDG CORP

$237.1M
KRYS

KRYSTAL BIOTECH INC

$234.9M
SRRK

SCHOLAR ROCK HLDG CORP

$230M
NRIX

NURIX THERAPEUTICS INC

$187.3M
KRYS

KRYSTAL BIOTECH INC

$175.5M
KRYS

KRYSTAL BIOTECH INC

$174M
KRYS

KRYSTAL BIOTECH INC

$167.1M